We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
401
J.M. Smucker
SJM
$13.5B
$9.01M 0.03%
82,596
+16,171
+24% +$1.83M
VERA icon
402
Vera Therapeutics
VERA
$2.33B
$8.91M 0.03%
246,201
-25,877
-10% -$1.03M
BXP icon
403
Boston Properties
BXP
$11.6B
$8.89M 0.03%
144,492
+26,844
+23% +$1.64M
SFM icon
404
Sprouts Farmers Market
SFM
$7.44B
$8.81M 0.03%
105,265
+9,827
+10% +$716K
MPC icon
405
Marathon Petroleum
MPC
$90.1B
$8.77M 0.03%
50,526
+29,665
+142% +$5.52M
HCA icon
406
HCA Healthcare
HCA
$90.6B
$8.59M 0.03%
26,731
-29,112
-52% -$9.46M
IDYA icon
407
IDEAYA Biosciences
IDYA
$3.43B
$8.55M 0.03%
243,484
+136
+0.1% +$5.39K
WAT icon
408
Waters Corp
WAT
$37.3B
$8.54M 0.03%
29,452
-18,292
-38% -$5.84M
APH icon
409
Amphenol
APH
$185B
$8.52M 0.03%
126,462
+44,926
+55% +$2.83M
HSY icon
410
Hershey
HSY
$37.3B
$8.51M 0.03%
46,303
+3,290
+8% +$637K
WFC icon
411
Wells Fargo
WFC
$254B
$8.49M 0.03%
142,999
-91,325
-39% -$5.39M
SLF icon
412
Sun Life Financial
SLF
$45.6B
$8.49M 0.03%
173,254
-33,505
-16% -$1.7M
CDW icon
413
CDW
CDW
$18.9B
$8.4M 0.03%
37,535
-524
-1% -$122K
JD icon
414
JD.com
JD
$43.5B
$8.4M 0.03%
325,053
+164,474
+102% +$4.83M
XRX icon
415
Xerox
XRX
$345M
$8.4M 0.03%
722,696
-122,685
-15% -$1.78M
CRH icon
416
CRH
CRH
$66.6B
$8.36M 0.02%
111,526
-6,477
-5% -$517K
FTNT icon
417
Fortinet
FTNT
$112B
$8.33M 0.02%
138,199
-215,755
-61% -$13.4M
CTVA icon
418
Corteva
CTVA
$60.5B
$8.32M 0.02%
154,197
+25,645
+20% +$1.41M
AYI icon
419
Acuity Brands
AYI
$9.99B
$8.21M 0.02%
34,004
+14,355
+73% +$3.67M
KAI icon
420
Kadant
KAI
$3.58B
$8.2M 0.02%
27,904
+46
+0.2% +$13.1K
FSLR icon
421
First Solar
FSLR
$21.4B
$8.17M 0.02%
36,233
-84,135
-70% -$18.3M
CNC icon
422
Centene
CNC
$30.5B
$8.12M 0.02%
122,540
-84,882
-41% -$6.17M
CLH icon
423
Clean Harbors
CLH
$17.2B
$8.06M 0.02%
35,641
-1,064
-3% -$223K
LFT
424
Lument Finance Trust
LFT
$38.6M
$8.02M 0.02%
3,340,780
DNLI icon
425
Denali Therapeutics
DNLI
$3.79B
$8.01M 0.02%
344,785
-16,023
-4% -$308K

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.